Qasim Hussaini

Current Term: 2024-26
Qasim Hussaini

Dr. Hussaini is an Assistant Professor of Medicine in the Division of Hematology & Oncology and a health systems researcher at the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham (UAB). His clinical focus is gastrointestinal cancers. His research focuses on health systems, law, and policy as it pertains to oncologic care, and his current work examines disparities in neighborhood and social context, financial/economic instability, and how policy could be effectively utilized to improve care access and delivery.

Dr. Hussaini’s team uses large database cancer, financial, and drug pricing registries, and prospective cohort linkages across these studies. He recently received a Young Investigator Award from American Society of Clinical Oncology (ASCO) for his work on contemporary mortgage discrimination and cancer outcomes. He has previously received 6 Conquer Cancer Foundation Merit Awards from ASCO for his work on biosimilar spending in Medicare Part D (2021), rural-urban disparities in mortality in GI cancers (2022), pembrolizumab price variability in NYC (2022), historical housing discrimination and contemporary cancer outcomes (2022), financial toxicity and bone marrow transplant (2023), and legal barriers in cancer care (2023).

Prior to beginning at UAB, he served as Chief Fellow at the Johns Hopkins Hospital, and helped set the clinical, education, and research direction for the programs including spearheading a Cancer Policy & Health Systems, Quality Improvement and Diversity, Equity and Inclusion initiatives. He also recently served as an ASCO JCO-OP Editorial Fellow. Prior to fellowship, he completed his residency training at the Duke University Hospital where his primary research focus on financial toxicity and institutional medical debt. He was the recipient of the Robert Califf Research Award, Eugene-Stead Research Award, and Faculty-Resident Research Award toward this work. Prior to residency, he completed medical school between Singapore and Duke where he focused on health policy in South Asia.